Sabra Health Care REIT (NASDAQ:SBRA) Releases Earnings Results, Hits Estimates

Sabra Health Care REIT (NASDAQ:SBRA) issued its earnings results on Wednesday. The real estate investment trust reported $0.36 earnings per share for the quarter, hitting the consensus estimate of $0.36, Zacks reports. Sabra Health Care REIT had a net margin of 14.20% and a return on equity of 3.51%. Sabra Health Care REIT updated its FY 2025 guidance to 1.430-1.460 EPS.

Sabra Health Care REIT Price Performance

Shares of Sabra Health Care REIT stock traded up $0.09 during trading hours on Wednesday, reaching $16.55. The company’s stock had a trading volume of 2,383,360 shares, compared to its average volume of 2,028,529. The firm has a 50 day moving average price of $16.92 and a 200-day moving average price of $17.63. The company has a debt-to-equity ratio of 0.90, a current ratio of 4.16 and a quick ratio of 4.16. The stock has a market cap of $3.92 billion, a P/E ratio of 40.37, a P/E/G ratio of 1.99 and a beta of 1.25. Sabra Health Care REIT has a one year low of $13.31 and a one year high of $20.03.

Sabra Health Care REIT Announces Dividend

The firm also recently disclosed a quarterly dividend, which will be paid on Friday, February 28th. Shareholders of record on Friday, February 14th will be paid a $0.30 dividend. The ex-dividend date of this dividend is Friday, February 14th. This represents a $1.20 dividend on an annualized basis and a dividend yield of 7.25%. Sabra Health Care REIT’s payout ratio is currently 292.69%.

Wall Street Analysts Forecast Growth

SBRA has been the subject of a number of recent analyst reports. Mizuho reaffirmed a “neutral” rating and issued a $20.00 price objective on shares of Sabra Health Care REIT in a research note on Thursday, December 5th. Citizens Jmp upgraded Sabra Health Care REIT from a “hold” rating to a “strong-buy” rating in a research note on Tuesday, January 7th. Truist Financial cut shares of Sabra Health Care REIT from a “buy” rating to a “hold” rating and reduced their price objective for the company from $18.00 to $17.00 in a research report on Friday, January 17th. Finally, JMP Securities raised shares of Sabra Health Care REIT from a “market perform” rating to an “outperform” rating and set a $20.00 target price for the company in a research note on Tuesday, January 7th. Three analysts have rated the stock with a hold rating, four have issued a buy rating and one has assigned a strong buy rating to the company. Based on data from MarketBeat.com, the company has a consensus rating of “Moderate Buy” and a consensus target price of $18.86.

About Sabra Health Care REIT

Sabra Health Care REIT, Inc engages in the business of acquiring, financing, and owning real estate property. The company was founded on May 10, 2010 and is headquartered in Tustin, CA.